Mitochondrial defects in cancer

por Carew, Jennifer S, Huang, Peng
Publicado 2002

Autophagy: New Insights into Its Roles in Cancer Progression and Drug Resistance

por Nawrocki, Steffan T., Wang, Wei, Carew, Jennifer S.
Publicado 2020

Autophagy as a target for cancer therapy: new developments

por Carew, Jennifer S, Kelly, Kevin R, Nawrocki, Steffan T
Publicado 2012

Therapeutic Targeting of Autophagy for Renal Cell Carcinoma Therapy

por Jones, Trace M., Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2020

Targeting autophagy: a novel anticancer strategy with therapeutic implications for imatinib resistance

por Carew, Jennifer S, Nawrocki, Steffan T, Giles, Francis J, Cleveland, John L
Publicado 2008

Nilotinib: optimal therapy for patients with chronic myeloid leukemia and resistance or intolerance to imatinib

por Swords, Ronan, Mahalingam, Devalingam, Padmanabhan, Swaminathan, Carew, Jennifer, Giles, Francis
Publicado 2009

Targeting NEDDylation as a Novel Approach to Improve the Treatment of Head and Neck Cancer

por Jones, Trace M., Carew, Jennifer S., Bauman, Julie E., Nawrocki, Steffan T.
Publicado 2021

Moving beyond hydroxychloroquine: the novel lysosomal autophagy inhibitor ROC-325 shows significant potential in preclinical studies

por Jones, Trace M., Espitia, Claudia, Wang, Wei, Nawrocki, Steffan T., Carew, Jennifer S.
Publicado 2019

Oncolytic Viruses for Multiple Myeloma Therapy

por Calton, Christine M., Kelly, Kevin R., Anwer, Faiz, Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2018

Targeting JAK/STAT Signaling Antagonizes Resistance to Oncolytic Reovirus Therapy Driven by Prior Infection with HTLV-1 in Models of T-Cell Lymphoma

por Islam, Shariful, Espitia, Claudia M., Persky, Daniel O., Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2021

Oncolytic reovirus inhibits angiogenesis through induction of CXCL10/IP-10 and abrogation of HIF activity in soft tissue sarcomas

por Carew, Jennifer S., Espitia, Claudia M., Zhao, Weiguo, Mita, Monica M., Mita, Alain C., Nawrocki, Steffan T.
Publicado 2017

Targeted CUL4A inhibition synergizes with cisplatin to yield long-term survival in models of head and neck squamous cell carcinoma through a DDB2-mediated mechanism

por Jones, Trace M., Espitia, Claudia M., Ooi, Aikseng, Bauman, Julie E., Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2022

The novel Aurora A kinase inhibitor MLN8237 is active in resistant chronic myeloid leukaemia and significantly increases the efficacy of nilotinib

por Kelly, Kevin R, Ecsedy, Jeffrey, Medina, Ernest, Mahalingam, Devalingam, Padmanabhan, Swaminathan, Nawrocki, Steffan T, Giles, Francis J, Carew, Jennifer S
Publicado 2011

Junctional adhesion molecule-A is overexpressed in advanced multiple myeloma and determines response to oncolytic reovirus

por Kelly, Kevin R., Espitia, Claudia M., Zhao, Weiguo, Wendlandt, Erik, Tricot, Guido, Zhan, Fenghuang, Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2015

Heightened JNK Activation and Reduced XIAP Levels Promote TRAIL and Sunitinib-Mediated Apoptosis in Colon Cancer Models

por Mahalingam, Devalingam, Carew, Jennifer S., Espitia, Claudia M., Cool, Robbert H., Giles, Francis J., de Jong, Steven, Nawrocki, Steffan T.
Publicado 2019

Targeting NEDDylation is a Novel Strategy to Attenuate Cisplatin-induced Nephrotoxicity

por Jones, Trace M., Espitia, Claudia M., Chipollini, Juan, Lee, Benjamin R., Wertheim, Jason A., Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2023

Oncolytic reovirus sensitizes multiple myeloma cells to anti-PD-L1 therapy

por Kelly, Kevin R., Espitia, Claudia M., Zhao, Weiguo, Wu, Kaijin, Visconte, Valeria, Anwer, Faiz, Calton, Christine M., Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2017

ELR510444 Inhibits Tumor Growth and Angiogenesis by Abrogating HIF Activity and Disrupting Microtubules in Renal Cell Carcinoma

por Carew, Jennifer S., Esquivel, Juan A., Espitia, Claudia M., Schultes, Christoph M., Mülbaier, Marcel, Lewis, Joe D., Janssen, Bernd, Giles, Francis J., Nawrocki, Steffan T.
Publicado 2012

ABCG2 Overexpression Contributes to Pevonedistat Resistance

por Kathawala, Rishil J., Espitia, Claudia M., Jones, Trace M., Islam, Shariful, Gupta, Pranav, Zhang, Yun-Kai, Chen, Zhe-Sheng, Carew, Jennifer S., Nawrocki, Steffan T.
Publicado 2020

Mitochondrial respiration defects in cancer cells cause activation of Akt survival pathway through a redox-mediated mechanism

por Pelicano, Hélène, Xu, Rui-hua, Du, Min, Feng, Li, Sasaki, Ryohei, Carew, Jennifer S., Hu, Yumin, Ramdas, Latha, Hu, Limei, Keating, Michael J., Zhang, Wei, Plunkett, William, Huang, Peng
Publicado 2006